The antiviral nasal sprays are having a hard time even though the most sensible simple safe protection and in some evidence treatments against covid BUT BIG PHARMA Pfizer acted fast via links to regulator funding and political lobbying to make sure Paxlovid didn’t get gazumped by antiviral nasal sprays
Nasodine and Viraleze have both been adversely effected and share price too
It will be interesting to see how the next Melbourne antiviral nasal sprays fares - in placebo trials at present. Supposedly independant and trial funded by VIC state govt grant of $4m+ but Heparin sulphate used in the trial is import sponsored by Pfizer…
The antiviral nasal sprays are having a hard time even though...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add FRE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.93M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 26208 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 147690 | 1 |
View Market Depth
| Last trade - 16.12pm 28/06/2024 (20 minute delay) ? |
| FRE (ASX) Chart |
Day chart unavailable